US 12121532
Modified antisense oligomers for exon inclusion in spinal muscular atrophy
granted A61KA61K31/712A61K31/7125
Quick answer
US patent 12121532 (Modified antisense oligomers for exon inclusion in spinal muscular atrophy) held by Sarepta Therapeutics, Inc. expires Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sarepta Therapeutics, Inc.
- Grant date
- Tue Oct 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/712, A61K31/7125, A61P, A61P21/00